Scatter plot of incremental cost-effectiveness ratios for the treatment (saxagliptin+metformin) arm versus control (acarbose+metformin) arm with a CE threshold value of ¥46,629 (GDP per capita in China in 2014).
- Shuyan Gu (736892)
- Yuhang Zeng (3328578)
- Demin Yu (3359162)
- Xiaoqian Hu (556383)
- Hengjin Dong (398458)
Publication date
November 2016
DOIAbstract
<p>Scatter plot of incremental cost-effectiveness ratios for the treatment (saxagliptin+metformin) arm versus control (acarbose+metformin) arm with a CE threshold value of ¥46,629 (GDP per capita in China in 2014).</p
Add to ORKG